STAT

DECEMBER 7, 2023

The news comes three months after Insulet, EOFlow’s rival, filed a lawsuit accusing the company of stealing trade secrets. In a filing with the Securities and Exchange Commission late Wednesday, Medtronic announced its cancellation of the deal. Medtronic is no longer buying EOFlow, a Korean maker of wearable insulin pumps.

128

128

STAT

MARCH 21, 2024

In a new test of xenotransplantation, a medical team at Massachusetts General Hospital announced Thursday that, for the first time, it had transplanted a kidney from a CRISPR gene-edited pig into a living patient. Surgeons performed the milestone procedure over four hours on Saturday, March 16, without complications.

Hospitals 145

Hospitals 145

STAT

SEPTEMBER 10, 2023

Headlines announce that transmission is surging and hospitalizations for Covid are rising by alarming percentages. 2.86 , spells bad news for our fall and winter , and whether soon-to-be-released booster shots will be a match for it or whatever variant follows. People are worrying about whether the latest subvariant, BA.2.86

Hospitals 145

Hospitals 145

Fierce Healthcare

APRIL 26, 2024

Below is a roundup of payer-centric news headlines for the week of April 22, 2024. This week, Molina Healthcare gave an update on the Florida and Virginia Medicaid awards process, UHG announced a $2 million grant for Native American behavioral health and new partnerships were unveiled by WellCare of Kentucky and Humana.

52

52

STAT

APRIL 1, 2024

News of the proposed deal broke last week, but neither of the two famously secretive companies would share details on the plan, including the purchase price.

Hospitals 127

Hospitals Insurance 127

Fierce Pharma

FEBRUARY 21, 2024

Top buyout firms, including Advent International and Blackstone, have their eye on Sanofi's consumer health business, according to the news service. Sanofi previously announced plans to split during this year's fourth quarter "at the earliest."

78

78

STAT

MARCH 8, 2024

The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians, forcing the community to consider just what to do with an approved medicine that doesn’t appear to work.

FDA 143

FDA 143

STAT

JANUARY 17, 2024

In early January, Eli Lilly announced a platform that allows patients to access and fill prescriptions for its drugs online, timing the news to the availability of its obesity medication Zepbound. Now, Big Pharma is ready to get in on the action.

128

128

STAT

JANUARY 25, 2024

The news comes a week after Humana already lowered its projected 2023 profit , which still came in at north of $3 billion before taxes. Humana went all-in on the program when it announced last year it would wind down its employer business , but that comes as regulators are beefing up scrutiny of MA plans.

Insurance 117

Insurance 117

STAT

OCTOBER 24, 2023

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one).

Compounding 133

Compounding 133

STAT

APRIL 24, 2024

Today we have some developments about Novo Nordisk’s insulin business, a side of the company that people don’t really talk about anymore, and some news about their GLP-1 business, a side that people can’t stop talking about. Good morning!

114

114

STAT

SEPTEMBER 7, 2023

Research institutions widely celebrated the news that a deal had been struck. In announcing the agreement Thursday, Prime Minister Rishi Sunak said U.K. Researchers and business groups have been calling for such a deal for months, warning that without membership, the U.K. Continue to STAT+ to read the full story…

111

111

STAT

NOVEMBER 22, 2023

With that public service announcement out of the way, here’s some news for you to peruse. The announcement marks a win for Pfizer and BioNTech in their ongoing feud with Moderna over intellectual property at the heart of their Covid-19 vaccines.

Vaccines 85

Vaccines 85

STAT

MAY 24, 2023

The founder of a small Boston-area   addiction treatment empire knew he was under scrutiny; the Globe and STAT News  published investigations  in 2017 and 2019 into his questionable business dealings, and the Massachusetts attorney general’s office announced   shortly after that   it was examining alleged scams involving (..)

145

145

STAT

JANUARY 9, 2023

The vaccine maker Novavax, which has faced several years of dramatic ups and downs around the development of its Covid-19 vaccine, announced Monday that its CEO of more than 11 years, Stanley Erck, would be stepping down. Investors had not been expecting the departure, but cheered the news.

Vaccines 89

Vaccines 89

STAT

JANUARY 10, 2024

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes.

138

138

STAT

MAY 4, 2023

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

FDA 92

FDA 92

Fierce Healthcare

JANUARY 9, 2024

Below is a round-up of payer-centric news for the week of Jan. 9 at 3:00 ET | This week, PBM Liviniti has announced a partnership with Noom, Michigan regulators take insurers to task for not covering cancer therapies and self-funded employer-sponsored insurance plans saw an uptick in enrollment. 2024 UPDATED: Tuesday, Jan.

Insurance 52

Insurance 52

STAT

NOVEMBER 10, 2023

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another. Medicare officials last week announced its major annual update to the way the program pays physicians.

118

118

STAT

NOVEMBER 23, 2022

Yale and Harvard Law Schools recently announced they would no longer participate in U.S. News & World Report’s (USNWR) flawed ranking system, followed closely by additional schools. The nation’s medical schools need to follow their lead.

Medical Schools 96

Medical Schools 96

STAT

OCTOBER 10, 2022

Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public. The news comes about a year after another large oncology provider chain hit the stock market. is about to have not just one, but two, standalone publicly-traded oncology providers.

96

96

The Guardian - Pharmaceutical Industry

SEPTEMBER 26, 2022

The health minister, Mark Butler, on Monday announced Australians will have expanded access to some medicines from 1 October, saving $130m a year in out-of-pocket costs.

67

67

STAT

MAY 19, 2023

It’s exciting news for Tune, which was founded in 2021 and is located in Durham, N.C., and Seattle, but also for the other young startups in this field trying to develop a new class of precision medicines that can write or erase epigenetic marks involved in human disease.

143

143

STAT

APRIL 12, 2023

Arnold Ventures, one of the largest nonprofit funders of criminal justice reform projects and a major player in drug policy circles, announced last month that Texas A&M University economist Jennifer Doleac would take over its criminal justice portfolio in July, replacing longtime policy reform researcher and public official Jeremy Travis.

98

98

STAT

APRIL 23, 2024

… Sanofi will pay more than $100 million to settle about 4,000 lawsuits accusing the drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer , according to Bloomberg News. The settlement was announced earlier this month, but the amount was not made public at that time.

99

99

Med Ed 101

JULY 2, 2023

CMS did make news in June and recently announced a new, voluntary primary care model called “Making Care Primary (MCP)” Model. Pharmacists’ scope of practice has been expanding and that growth has been done on the state level. The federal level has been stagnant for quite some time.

59

59

European Pharmaceutical Review

OCTOBER 16, 2023

Announcement a new ADC filling line signifies another milestone for Lonza. It follows completion of a new filling line in Visp, at the end of March 2023, which was created to add capacity and capabilities for cGMP clinical and commercial drug product manufacturing. This was funded investment of approximately £455 million.

Compounding 91

Compounding 91

Outsourcing Pharma

SEPTEMBER 1, 2022

This monthâs announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

52

52

European Pharmaceutical Review

FEBRUARY 14, 2023

Johnson & Johnson ( J&J ) has announced that Dr John Reed, PhD, will become the company’s Executive Vice President of Pharmaceuticals, R&D on April 3, 2023. Johnson & Johnson today announced the appointment of John Reed, M.D., to the Company’s Executive Committee as Executive Vice President of Pharmaceuticals, R&D.

Hospitals 80

Hospitals 80

STAT

JANUARY 26, 2023

If the buzz is to be believed, ChatGPT seems poised to upend everything from high school essays and news articles to computer coding and scientific research. The program has generated huge interest for its ability to write nearly anything it’s asked to write and to answer questions.

Hospitals 101

Hospitals 101

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Elsewhere, San Diego, California-based Heron Therapeutics announced restructuring and layoffs for 34% of its workforce. This is particularly felt among smaller retail investors.

129

129

Outsourcing Pharma

MARCH 3, 2022

This monthâs announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

52

52

European Pharmaceutical Review

JULY 21, 2023

Supporting European biosimilar development Continued investment in biosimilars The planned financing builds on Sandoz’s announced investment in March 2023 of $400 million in a new biologics manufacturing plant in Lendava, Slovenia.

87

87

Pharma Times

JULY 19, 2023

Illumina and Nashville Biosciences’ have announced AbbVie, Amgen, AstraZeneca, Bayer and Merck as founding members - News - PharmaTimes

41

41

STAT

JANUARY 4, 2024

… Starting April 1, CVS Health will no longer offer AbbVie’s Humira to patients in its commercial prescription plans and, instead, will direct them to biosimilar versions of the anti-inflammatory drug that became available last year , Bloomberg News writes.

FDA 118

FDA 118

Pharmafile

MARCH 1, 2023

US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. The Muscular Dystrophy Association (MDA) has welcomed the news, after having a direct impact in the research of FA. This approval came on Rare Disease Day. read more

FDA 52

FDA Communication 52

Outsourcing Pharma

DECEMBER 2, 2021

This monthâs announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

52

52